(Total Views: 503)
Posted On: 01/15/2022 3:20:25 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
interesting about so. korea they already have a mab regdanvimab by celltrion but not close to what leronlimab can offer.
https://www.biopharma-reporter.com/Article/20...antibodies
https://www.biopharma-reporter.com/Article/20...antibodies
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)